Astra
lifecare was formed in February 2004 and came into commercial production in
April 2006. The major expansion was completed in FY2011-12 and doubled the
existing capacity of the plant to cater the growing demand of the existing
market as well as to expand the global marketing horizon of the Company. The facility is established to manufacture
all types of Solid Oral formulation. This plant has dedicated facilities for
General and Beta-lactum products and are equipped with latest technology
equipments. Our in-house Quality Assurance & Control department is also
facilitated with modern technology laboratory equipments to meet the
international standards. The facility
is WHO-cGMP compliant and have also been approved by National Drug Authority of
Uganda, Tanzania Food and Drug Authority, Pharmacy and Poisons Board of Kenya,
Drug Administration and Control Authority of Ethiopia, Ministry of Health of
D.R. Congo and Pharmacy, Medicines & Poisons Board of Malawi. Our long-term
aim is to obtain other international regulatory approvals like, TGA-Australia,
MHRA-UK, MCC-South Africa, USFDA.
No comments:
Post a Comment